Bridgecreek Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bridgecreek Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-38,517	Closed	-$4.92M	–	112
2018 Q3	$4.92M	Hold	38,517	–	–	0.98%	40
2018 Q2	$4.17M	Sell	38,517 -252	-0.7%	-$27.4K	0.91%	49
2018 Q1	$4.1M	Hold	38,769	–	–	0.92%	50
2017 Q4	$4.54M	Sell	38,769 -1,283	-3%	-$145K	1.07%	47
2017 Q3	$4.55M	Buy	40,052 +660	+2%	+$76.2K	1.24%	35
2017 Q2	$4.91M	Buy	39,392 +6,314	+19%	+$749K	1.31%	37
2017 Q1	$3.92M	Buy	33,078 +9,306	+39%	+$1.05M	1.06%	45
2016 Q4	$2.38M	Buy	+23,772	New	+$2.55M	0.67%	58

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bridgecreek Investment Management's ZBH Position: Q4 2018 in Review

Bridgecreek Investment Management sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 38,517 shares — an estimated $4.92M sold.

Bridgecreek Investment Management first reported a position in ZBH in Q4 2016 and held it in 8 quarters. The position peaked at $4.92M in Q3 2018. 872 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

Bridgecreek Investment Management reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
Bridgecreek Investment Management sold 38,517 Zimmer Biomet shares in Q4 2018, an estimated $4.92M.
Bridgecreek Investment Management first reported a position in Zimmer Biomet in Q4 2016 and held it in 8 quarters.
Bridgecreek Investment Management's Zimmer Biomet position peaked at $4.92M in Q3 2018.
872 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Bridgecreek Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.